Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

INDIV 1

Study Type

Interventional 7Observational 1

Sponsor

Conditions

Breast Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma 3Myelodysplastic Syndromes 2Unspecified Childhood Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Recurrence 1Pancreatic Neoplasms 1Ototoxicity 1Neurotoxicity Syndromes 1Neoplasm, Residual 1Neoplasm Metastasis 1Myasthenia Gravis 1Multiple Myeloma 1Microbiota 1Metabolic Diseases 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Immunologic Deficiency Syndromes 1Immunoglobulin Light-chain Amyloidosis 1Hormone Refractory Prostate Cancer 1Fatigue 1Central Nervous System Neoplasms 1Breast Cancer Organoids 1Breast Cancer Metastatic 1Brain Neoplasms 1

Interventions

ravulizumab 3Tacrolimus 3Pyridostigmine Bromide 3Prednisone 3Mycophenolic Acid 3Data Collection 3Azathioprine 3efgartigimod alfa 2Steroids 2Diagnostic Self Evaluation 2Blood Specimen Collection 2rozanolixizumab 1Thymectomy 1Therapeutics 1Telemedicine 1Neurofeedback 1Methylprednisolone 1Methotrexate 1Immunosuppressive Agents 1Immunoglobulins, Intravenous 1Genotype 1Cyclosporine 1Cyclophosphamide 1Biomarkers 1Alleles 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Myasthenia Gravis × Cyclophosphamide × Clear all
NCT04101578 2021-08-23

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Da, Yuwei, M.D.

Unknown
2,000 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡